![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 15
2016
Pfirrmann, Markus; Baccarani, M.; Saußele, Susanne; Guilhot, J.; Cervantes, F.; Ossenkoppele, G.; Hoffmann, V. S.; Castagnetti, F.; Hasford, Joerg; Hehlmann, R. und Simonsson, B.
(2016):
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia.
In: Leukemia, Bd. 30, Nr. 1: S. 48-56
Hoffmann, V. S.; Baccarani, M.; Hasford, Joerg; Castagnetti, F.; Raimondo, F. di; Simonsson, B.; Indrak, K.; Sninska, Z.; Sacha, T.; Clark, R.; Bogdanovic, A.; Hellmann, A.; Griskevicius, L.; Schubert-Fritschle, Gabriele; Sertic, D.; Guilhot, J.; Lejniece, S.; Zupan, I.; Burgstaller, S.; Koskenvesa, P.; Everaus, H.; Costeas, P.; Lindörfer, Doris; Rosti, G.; Saussele, S.; Hochhaus, A.; Hehlmann, R.; Turkina, A. und Casado, L. F.
(2016):
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.
In: Leukemia, Bd. 31, Nr. 3: S. 593-601
2015
Pfirrmann, Markus; Lauseker, Michael; Hoffmann, V. S. und Hasford, Joerg
(2015):
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.
In: Annals of Hematology / Supplements, Bd. 94, Nr. 2:
S209-18
Lauseker, Michael; Hasford, Joerg; Hoffmann, V. S.; Mueller, M. C.; Hehlmann, R. und Pfirrmann, Markus
(2015):
A multi-state model approach for prediction in chronic myeloid leukaemia.
In: Annals of Hematology, Bd. 94, Nr. 6: S. 919-927
Meinel, F. G.; Nance, J. W. Jr.; Schoepf, U. J.; Hoffmann, V. S.; Thierfelder, K. M.; Costello, P.; Goldhaber, S. Z. und Bamberg, F.
(2015):
Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis.
In: American Journal of Medicine, Bd. 128, Nr. 7, 747-759 e2
Hoffmann, V. S.; Baccarani, M.; Hasford, Joerg; Lindörfer, Doris; Burgstaller, S.; Sertic, D.; Costeas, P.; Mayer, J.; Indrak, K.; Everaus, H.; Koskenvesa, P.; Guilhot, J.; Schubert-Fritschle, Gabriele; Castagnetti, F.; Di Raimondo, F.; Lejniece, S.; Griskevicius, L.; Thielen, N.; Sacha, T.; Hellmann, A.; Turkina, A. G.; Zaritskey, A.; Bogdanovic, A.; Sninska, Z.; Zupan, I.; Steegmann, J. L.; Simonsson, B.; Clark, R. E.; Covelli, A.; Guidi, G. und Hehlmann, R.
(2015):
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
In: Leukemia, Bd. 29, Nr. 6: S. 1336-1343
Hoffmann, V. S.; Neumann, L.; Golgert, S. und Renteln-Kruse, W. von
(2015):
Pro-Active Fall-Risk Management Is Mandatory to Sustain in Hospital-Fall Prevention in Older Patients - Validation of the LUCAS Fall-Risk Screening in 2,337 Patients.
In: Journal of Nutrition, Health & Aging, Bd. 19, Nr. 10: S. 1012-1018
Hetterich, H.; Willner, M.; Habbel, C.; Herzen, J.; Hoffmann, V. S.; Fill, S.; Hipp, A.; Marschner, M.; Schuller, U.; Auweter, S.; Massberg, S.; Reiser, M. F.; Pfeiffer, F.; Saam, T. und Bamberg, F.
(2015):
X-ray phase-contrast computed tomography of human coronary arteries.
In: Investigative Radiology, Bd. 50, Nr. 10: S. 686-694
2013
Neumann, L.; Hoffmann, V. S.; Golgert, S.; Hasford, Joerg und Renteln-Kruse, W. von
(2013):
In-Hospital Fall-Risk Screening in 4,735 Geriatric Patients from the LUCAS Project.
In: Journal of Nutrition, Health & Aging, Bd. 17, Nr. 3: S. 264-269
Sattler, E. C.; Maier, T.; Hoffmann, V. S.; Ruzicka, T. und Berking, C.
(2013):
Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy: Reply from authors.
In: British Journal of Dermatology, Bd. 169, Nr. 1: S. 213-215
Hoffmann, V. S.; Baccarani, M.; Lindörfer, Doris; Castagnetti, F.; Turkina, A.; Zaritsky, A.; Hellmann, A.; Prejzner, W.; Steegmann, J. L.; Mayer, J.; Indrak, K.; Colita, A.; Rosti, G. und Pfirrmann, Markus
(2013):
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib.
In: Leukemia, Bd. 27, Nr. 10: S. 2016-2022
2012
Lauseker, Michael; Pfirrmann, Markus; Hoffmann, V. S. und Hasford, Joerg
(Mai 2012):
Comment On “Second-Generation Tyrosine Kinase Inhibitors Improve The Survival Of Patients With Chronic Myeloid Leukemia In Whom Imatinib Therapy Has Failed” Haematologica 2011;96(12):1779–82.
In: Haematologica, Bd. 97, Nr. 5, e14-e15
Sattler, E. C.; Maier, T.; Hoffmann, V. S.; Hegyi, J.; Ruzicka, T. und Berking, C.
(2012):
Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy.
In: British Journal of Dermatology, Bd. 167, Nr. 5: S. 1042-1047
Andrassy, J.; Hoffmann, V. S.; Rentsch, M.; Stangl, M.; Habicht, A.; Meiser, B.; Fischereder, M.; Jauch, Karl-Walter und Guba, M.
(2012):
Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor-Based Immunosuppression? A Systematic Review and Meta-Analysis.
In: Transplantation, Bd. 94, Nr. 12: S. 1208-1217
Büchner, T.; Schlenk, R. F.; Schaich, M.; Doehner, K.; Krahl, R.; Krauter, J.; Heil, G.; Krug, U.; Sauerland, M. C.; Heinecke, A.; Späth, Daniela; Kramer, M.; Scholl, S.; Berdel, W. E.; Hiddemann, Wolfgang; Hoelzer, D.; Hehlmann, R.; Hasford, Joerg; Hoffmann, V. S.; Doehner, H.; Ehninger, G.; Ganser, A.; Niederwieser, D. W. und Pfirrmann, Markus
(2012):
Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm‐Combined Prospective Analysis by the German AML Intergroup.
In: Journal of Clinical Oncology, Bd. 30, Nr. 29: S. 3604-3610